[Federal Register Volume 88, Number 59 (Tuesday, March 28, 2023)]
[Notices]
[Page 18318]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-06316]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Breast Cancer in Young Women; Meeting

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with regulatory provisions, the Centers for 
Disease Control and Prevention (CDC) announces the following meeting 
for the Advisory Committee on Breast Cancer in Young Women (ACBCYW). 
This meeting is open to the public, limited only by audio and web 
conference lines (150 web conference participant spaces available). 
Online registration is required.

DATES: The meeting will be held on May 10, 2023, 11 a.m. to 4:30 p.m., 
EDT.

ADDRESSES: This meeting is virtual. Online Registration Required: All 
ACBCYW Meeting participants must register for the meeting online at 
least 2 business days in advance at https://www.cdc.gov/cancer/breast/what_cdc_is_doing/conference.htm. Please complete all the required 
fields and submit your registration no later than May 8, 2023. 
Registered participants will receive the audio and web conference 
access instructions before the meeting.

FOR FURTHER INFORMATION CONTACT: Kimberly E. Smith, MBA, MHA, 
Designated Federal Officer, National Center for Chronic Disease 
Prevention and Health Promotion, Centers for Disease Control and 
Prevention, 4770 Buford Hwy. NE, Mailstop S107-4, Atlanta, Georgia 
30341, Telephone (404) 498-0073, Fax (770) 488-4760. Email: 
[email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The Committee provides advice and guidance to the 
Secretary, HHS; the Assistant Secretary for Health; and the Director, 
CDC, regarding the formative research, development, implementation and 
evaluation of evidence-based activities designed to prevent breast 
cancer (particularly among those at heightened risk) and promote the 
early detection and support of young women who develop the disease. The 
advice provided by the Committee will assist in ensuring scientific 
quality, timeliness, utility, and dissemination of credible appropriate 
messages and resource materials.
    Matters to be Considered: The agenda will include discussions on 
current topics related to breast cancer in young women. These will 
include Mental/Behavioral Health, Sexual Health, Genetics and Genomics, 
and Provider Engagement. Agenda items are subject to change as 
priorities dictate.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-06316 Filed 3-27-23; 8:45 am]
BILLING CODE 4163-18-P